Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care

Abramson Cancer Center at Penn Medicine120 enrolled

Overview

The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

120

Conditions

Non-Small Cell Lung Carcinoma (NSCLC)

Interventions

SurveyOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All participants must be 18 years of age or older. * Patient participants must have Stage III, IV and/or recurrent NSCLC. * Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change * Patients must have working email address and internet access Exclusion Criteria: * Any participant who cannot understand written or spoken English. * Any participant who is not competent to provide informed consent for study participation per the investigator. * Any participant who cannot be present for the related study visits and/or complete the post-test assessment

Locations (1)

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Number of patient who completed surveys

Time frame: 8 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.